Levetiracetam impurity 1, with the CAS number 1342566-28-2, is a chemical compound associated with the pharmaceutical agent levetiracetam, which is primarily used as an anticonvulsant in the treatment of epilepsy. This impurity is typically a byproduct of the synthesis of levetiracetam and may exhibit structural similarities to the parent compound. The characteristics of this impurity can include its molecular formula, which reflects its elemental composition, and its molecular weight, which is indicative of the size of the molecule. Additionally, it may possess specific physical properties such as solubility in various solvents, melting point, and boiling point, which are essential for understanding its behavior in pharmaceutical formulations. The presence of impurities like levetiracetam impurity 1 is critical to monitor in drug development and quality control, as they can affect the efficacy and safety of the final pharmaceutical product. Analytical techniques such as HPLC or mass spectrometry are often employed to identify and quantify such impurities in drug substances.

Levetiracetam impurity 1

1342566-28-2: Levetiracetam impurity 1, with the CAS number 1342566-28-2, is a chemical compound associated with the pharmaceutical agent levetiracetam, which is primarily used as an anticonvulsant in the treatment of epilepsy. This impurity is typically a byproduct of the synthesis of levetiracetam and may exhibit structural similarities to the parent compound. The characteristics of this impurity can include its molecular formula, which reflects its elemental composition, and its molecular weight, which is indicative of the size of the molecule. Additionally, it may possess specific physical properties such as solubility in various solvents, melting point, and boiling point, which are essential for understanding its behavior in pharmaceutical formulations. The presence of impurities like levetiracetam impurity 1 is critical to monitor in drug development and quality control, as they can affect the efficacy and safety of the final pharmaceutical product. Analytical techniques such as HPLC or mass spectrometry are often employed to identify and quantify such impurities in drug substances.

CAS 1342566-28-2

Levetiracetam impurity 1

Levetiracetam Impurity 27 HCl

Ref: 4Z-L-0531